By providing consent, you agree to receive direct marketing and promotional materials (for example email communications) relating to Entrepreneurs First's services or related products. In addition, EF may share your data with associated portfolio companies you have expressed an interest in.
If you experience any technical issues, please get in touch with [email protected].
Read and confirm
By accessing this website here (“website”), you signify your unconditional agreement with and understanding of the terms of use and legal information pertaining to both this website and any information provided on this website hereon (“Site Content”). Full terms can be found here.
This communication is only intended for professional or accredited investors who have the relevant experience, knowledge and competence to make their own investment decisions and properly assess the risks involved. Entrepreneurs First Investment Manager LLP (“EFIM”) does not act as an ‘independent financial adviser’ for the purposes of UK law and cannot be held responsible for any financial or other consequences resulting from the decision you may make on the basis of this Site Content.
The information provided on this website and Site Content is not intended as a recommendation to purchase, sell or hold any shares or security or suggest that you pursue any investment style or strategy. Under no circumstances should anything herein be construed as an offer to sell or solicitation of interest to purchase any securities, including any securities of EFIM or any entities managed or advised by EFIM (together being, “Entrepreneurs First”) or any securities of Entrepreneurs First’s portfolio companies.
Before investing in any product, an investor should conduct their own risk analysis, fully understand all the risks involved and consult with their own professional advisors before making an investment decision, if there is any doubt as to the suitability of the products or services offered. Investing involves risk of loss, including risk of losing substantially all of your investment, which you should be prepared to bear.
Please click to confirm you have read and understood the information above. By doing so, you confirm that you are qualified as an investor to access the website and Site Content as described above.
Added to Shortlist
Request intro
My shortlist
No companies shortlisted
Fill in your details to request an introduction to your shortlisted companies.
APRIL 2025
DEMO DAY
ADDING TO SHORTLIST
Compile a shortlist of companies and request multiple introductions at once.
A51
Programmable RNA therapeutics for complex diseases. Within just a few months, A51 achieved a proof of biology and technology across the tech stack (computational, cellular assays, and microfluidics), obtained 2 LOIs from top pharma players, and kicked off a partnership with a top US university.
Delaware C
APMI
Vertical AI agents for short-term rental property management. APMI is working with 100+ carefully selected properties in private beta, with 80% of messages already being sent by AI. In just 3 months, they've built a live-chat mobile app with multiple AI agents handling workflows autonomously. They will be based in Europe and the US.
Delaware C
APMI
Vertical AI agents for short-term rental property management. APMI is working with 100+ carefully selected properties in private beta, with 80% of messages already being sent by AI. In just 3 months, they've built a live-chat mobile app with multiple AI agents handling workflows autonomously. They will be based in Europe and the US.
Appstack
Disrupting mobile app measurement with reliable data and AI-powered performance insights. Appstack has built a waitlist of more than 250 companies, built its platform with multi-million-dollar app studios, and already onboarded 20 companies with $100K revenue opportunity.
Delaware C
Ariana.dev
Automatically fixing bugs by analyzing code while it runs. In under 6 weeks, Ariana.dev hit 1,500 users, and is growing 30% WoW.
Delaware C
Asterix Health
Building the Doctor OS to solve the healthcare staffing crisis. London-based Asterix Health has launched profitable pilots worth £45K, with £12M ARR in pipeline. They signed LOIs with providers covering 8M+ patients and are the only company in the country with regulatory approval to employ doctors based abroad to work for UK healthcare providers, at a fraction of the cost.
United Kingdom
Asterix Health
Building the Doctor OS to solve the healthcare staffing crisis. London-based Asterix Health has launched profitable pilots worth £45K, with £12M ARR in pipeline. They signed LOIs with providers covering 8M+ patients and are the only company in the country with regulatory approval to employ doctors based abroad to work for UK healthcare providers, at a fraction of the cost.
Aule Space
Jetpacks for life-extension of satellites. Aule Space has designed GEO jetpack satellites for leading GEO satellite operators and has successfully tested prototypes on proprietary testbeds, the fastest ever built globally. They are launching payloads in November 2025 and have forged strategic partnerships to establish a robust satellite servicing infrastructure.
Delaware C
Aule Space
Jetpacks for life-extension of satellites. Aule Space has designed GEO jetpack satellites for leading GEO satellite operators and has successfully tested prototypes on proprietary testbeds, the fastest ever built globally. They are launching payloads in November 2025 and have forged strategic partnerships to establish a robust satellite servicing infrastructure.
Autoset
Generate targeted data to make AI systems better. Autoset currently has a $70K contract. Within ~6 weeks of outreach, they’ve converted over 50% of contacted leads into prospects, resulting in 5 late-stage and multiple early-stage discussions.
Delaware C
Bubble Robotics
Building the autonomous workforce for the ocean. In their first 3 months, Bubble Robotics signed $3.8M in LOIs with world-class offshore wind players. They are shaping the future of underwater autonomy alongside the top 3 marine labs on the planet. They will be based in Europe and the US.
Delaware C
Bubble Robotics
Building the autonomous workforce for the ocean. In their first 3 months, Bubble Robotics signed $3.8M in LOIs with world-class offshore wind players. They are shaping the future of underwater autonomy alongside the top 3 marine labs on the planet. They will be based in Europe and the US.
Callosum
The virtualization layer for heterogenous compute. Callosum built their prototype within a few months. They have validated market fit with top enterprise advisors and signed with global hardware vendors to scale their tech. They will be based between London and SF.
Delaware C
ChronosDx
Ultrasensitive, scalable and implantable biosensing on a chip, powering the future of how diseases are found. ChronosDx has developed an organic semiconductor-based biosensing technology which has attomolar sensitivity, is 100,000x better than SOTA immunoassay, has point of care speed <20 min, and is a fraction of the cost of existing solutions. Based in the UK, they secured 2 government grants, and are piloting with labs and major US and global diagnostic companies.
United Kingdom
ChronosDx
Ultrasensitive, scalable and implantable biosensing on a chip, powering the future of how diseases are found. ChronosDx has developed an organic semiconductor-based biosensing technology which has attomolar sensitivity, is 100,000x better than SOTA immunoassay, has point of care speed <20 min, and is a fraction of the cost of existing solutions. Based in the UK, they secured 2 government grants, and are piloting with labs and major US and global diagnostic companies.
Crane Biosciences
Red blood cell-derived nanoparticle platform for targeted mRNA delivery to the brain. Based at the Imperial College Incubator in London, Crane Biosciences achieved unprecedented >75% brain mRNA delivery in vivo, signed a $50K LOI with Massachusetts General Hospital, and is under CDA with 3 top 10 pharmas for its first deal.
Delaware C
Crane Biosciences
Red blood cell-derived nanoparticle platform for targeted mRNA delivery to the brain. Based at the Imperial College Incubator in London, Crane Biosciences achieved unprecedented >75% brain mRNA delivery in vivo, signed a $50K LOI with Massachusetts General Hospital, and is under CDA with 3 top 10 pharmas for its first deal.
Delfa
Building AI agents to automate clinical trials, starting with patient recruitment. In only 8 weeks Delfa has $195K in committed revenue. They are deployed live on 14 clinical trials, and have achieved 300% MoM product usage growth.
Delaware C
Fleetcraft
Powering the next era of flight with AI-native aircraft engineering. In 12 weeks, Fleetcraft has launched with a maintenance org managing an aircraft for a large EU airline. They are in late stage talks with 2 large US airlines for $100K+ annual contracts, and have a $45K pilot contract out for signing with the largest seaplane operator in the world.
Delaware C
Fleetcraft
Powering the next era of flight with AI-native aircraft engineering. In 12 weeks, Fleetcraft has launched with a maintenance org managing an aircraft for a large EU airline. They are in late stage talks with 2 large US airlines for $100K+ annual contracts, and have a $45K pilot contract out for signing with the largest seaplane operator in the world.
HelmGuard AI
The first cybersecurity superintelligence platform. HelmGuard redefines the security stack for the AI era, delivering continuous cybersecurity intelligence tailored specifically to your users and AI systems. Based in London, UK, they have active pilots at top financial firms and 4 late-stage deals worth $100K+.
Delaware C
HelmGuard AI
The first cybersecurity superintelligence platform. HelmGuard redefines the security stack for the AI era, delivering continuous cybersecurity intelligence tailored specifically to your users and AI systems. Based in London, UK, they have active pilots at top financial firms and 4 late-stage deals worth $100K+.
InteractionLabs
Physical AI-powered companions for kids. InteractionLabs created the first conversational AI running on $1 hardware, outperforming ChatGPT's voice mode in latency. They have 5,000+ child-AI interactions already, and have closed a beta with 50 paying customers.
Delaware C
Locksmith Bio
Modeling protein disorder for drugging the undruggable. Locksmith Bio has built a physics based AI for mapping protein disorder, as well as a POC for their hardware. They are advised by the top scientists in protein disorder, are enrolled in Sanofi's external innovation program and have an EOI from a leading pharmaceutical company.
Delaware C
Locksmith Bio
Modeling protein disorder for drugging the undruggable. Locksmith Bio has built a physics based AI for mapping protein disorder, as well as a POC for their hardware. They are advised by the top scientists in protein disorder, are enrolled in Sanofi's external innovation program and have an EOI from a leading pharmaceutical company.
Lucent
Cursor for video ads. Enabling marketers to go from idea to ad in minutes. Lucent has built a fully functional AI video studio in 4 weeks. They generated $1.2M+ pipeline within 6 weeks growing 140% weekly, and convinced the product lead at a direct competitor to join them.
Delaware C
Mutable Tactics
Physical AI for collaborative robotics, starting with defense. Based in the UK, Mutable Tactics beat 75 teams - including primes - to win a Danish-Ukrainian counter-drone competition, a $15B+ defense priority.
Delaware C
Paracosmic
Building the next generation of games, powered by world models. Paracosmic is building an "engine-less" game platform with interactive video models: producing game worlds from just a sentence and an image. They're pioneering new tools to create novel game experiences and unleash the next wave of UGC gaming.
Delaware C
Paracosmic
Building the next generation of games, powered by world models. Paracosmic is building an "engine-less" game platform with interactive video models: producing game worlds from just a sentence and an image. They're pioneering new tools to create novel game experiences and unleash the next wave of UGC gaming.
Parakeet Security
The security layer for Voice AI. In a few months Parakeet Security has $250K revenue deals in the pipeline, alongside 6 pilots and 9 design partnerships with international enterprises - unheard of for seed-stage startups in the cyber industry.
Delaware C
Peripheral Labs
Spatially intelligent models for live media. Peripheral Labs is working on a $150K design partnership with the Toronto Raptors, and already has design partnerships with the Sacramento Kings, Fox Sports, and Professional Fighters League.
Delaware C
Pyto
The highest-converting voice AI for inbound sales growth. In just 4 months, Pyto generated $375K ARR globally in the world's most competitive market: go-to-market SaaS.
Delaware C
Reflolabs
Using vertical AI to unlock revenue from returns. Reflolab's proprietary model already achieves more than 95% accuracy in defect analysis for shoes. Their MVP processes returns 50x faster than humans, and they could capture 7-figure TCV with their pipeline customers.
Delaware C
Ressl AI
Coding agents for Salesforce implementation. Ressl AI is live with 4 customers and has ~$100K in committed ARR. In only 8 weeks, they’ve solved 320+ tickets, and their AI agents are capable of automating 80% of what a BPO would do.
Delaware C